Spatial configuration of hepatitis e virus antigenic domain

Journal of Virology

Volumn 85, Issue 2, 2011, Pages 1117-1124

  Xing, Li ^a,b   Wang, Joseph C ^a   Li, Tian Cheng ^c   Yasutomi, Yasuhiro ^d   Lara, James ^e   Khudyakov, Yury ^e   Schofield, Darren ^f   Emerson, Suzanne U ^f   Purcell, Robert H ^f   Takeda, Naokazu ^c   Miyamura, Tatsuo ^c   Cheng, R Holland ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS CAPSID ANTIGEN; VIRUS PROTEIN; VIRUS PROTEIN FAB224;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; FEMALE; HEPATITIS E VIRUS; IMAGE RECONSTRUCTION; IMMUNITY; MOLECULAR DOCKING; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; CRYOELECTRON MICROSCOPY; EPITOPES; FEMALE; HEPATITIS E VIRUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SEQUENCE DELETION; SPODOPTERA; VIROSOMES;

HEPATITIS E VIRUS; HEXAPODA; MIRIDAE;

EID: 78650672792     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00657-10     Document Type: Article

References (33)

1. Adler, B., and S. Faine. 1983. A pomona serogroup-specific, agglutinating antigen in Leptospira, identified by monoclonal antibodies. Pathology 15: 247-250.
2. Baker, T., and H. Cheng. 1996. A model based approach for determining orientations of biological macromolecules imaged by cryo-electron microscopy. J. Struct. Biol. 116:120-130.
3. Bendall, R. P., V. Ellis, S. Ijaz, P. Thurairajah, and H. R. Dalton. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J. Med. Virol. 80:95-101.
4. Crowther, R. A. 1971. Procedures for three-dimensional reconstruction of spherical viruses by Fourier synthesis from electron micrographs. Philos. Trans. R. Soc. Lond. B Biol. Sci. 261:221-230.
5. DeLano, W. L. 2002. The PYMOL molecular graphics system. DeLano Scientific, Palo Alto, CA.
6. Deshmukh, T. M., K. S. Lole, A. S. Tripathy, and V. A. Arankalle. 2007. Immunogenicity of candidate hepatitis E virus DNA vaccin e expressing complete and truncated ORF2 in mice. Vaccine 25:4350-4360.
7. Emerson, S., P. Clemente-Casares, N. Moiduddin, V. A. Arankalle, U. Torian, and R. Purcell. 2006. Putative neutralization epitopes and broad crossgenotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay. J. Gen. Virol. 87:697-704.
8. Guu, T., Z. Liu, Q. Ye, D. Mata, K. Li, C. Yin, J. Zhang, and Y. Tao. 2009. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. U. S. A. 106:12992-12997.
9. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved method for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47(Pt. 2):110-119.
10. Khuroo, M. S., and M. S. Khuroo. 2008. Hepatitis E virus. Curr. Opin. Infect. Dis. 21:539-543.
11. Li, S., S. Tang, J. Seetharaman, C. Y. Yang, Y. Gu, J. Zhang, H. Du, J. W. Shih, C. L. Hew, J. Sivaraman, and N. S. Xia. 2009. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog. 5:e1000537.
12. Li, T.-C., Y. Suzaki, Y. Ami, T. N. Dhole, T. Miyamura, and N. Takeda. 2004. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 22:370-377.
13. Li, T.-C., N. Takeda, T. Miyamura, Y. Matsuura, J. C. Y. Wang, H. Engvall, L. Hammar, L. Xing, and R. H. Cheng. 2005. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J. Virol. 79:12999-13006.
14. Li, T., N. Takeda, and T. Miyamura. 2001. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 19:3476-3484.
15. Li, T. C., Y. Yamakawa, K. Suzuki, M. Tatsumi, M. A. Razak, T. Uchida, N. Takeda, and T. Miyamura. 1997. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71:7207-7213.
16. Maloney, B. J., N. Takeda, Y. Suzaki, Y. Ami, T. C. Li, T. Miyamura, C. J. Arntzen, and H. S. Mason. 2005. Challenges in creating a vaccine to prevent hepatitis E. Vaccine 23:1870-1874.
17. Minuk, G. Y., A. Sun, D. F. Sun, J. Uhanova, L. E. Nicolle, B. Larke, and A. Giulivi. 2007. Serological evidence of hepatitis E virus infection in an indigenous North American population. Can J. Gastroenterol. 21:439-442.
18. Mushahwar, I. K. 2008. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J. Med. Virol. 80:646-658.
19. Naik, S. R., R. Aggarwal, P. N. Salunke, and N. N. Mehrotra. 1992. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull. World Health Organ. 70:597-604.
20. Niikura, M., S. Takamura, G. Kim, S. Kawai, M. Saijo, S. Morikawa, I. Kurane, T. C. Li, N. Takeda, and Y. Yasutomi. 2002. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 293:273-280.
21. Pavio, N., and J. M. Mansuy. 2010. Hepatitis E in high-income countries. Curr. Opin. Infect. Dis. 23:521-527.
22. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
23. Riddell, M. A., F. Li, and D. A. Anderson. 2000. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J. Virol. 74:8011-8017. (Pubitemid 30641646)
24. Robinson, R. A., W. H. Burgess, S. U. Emerson, R. S. Leibowitz, S. A. Sosnovtseva, S. Tsarev, and R. H. Purcell. 1998. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr. Purif. 12:75-84.
25. Schofield, D. J., J. Glamann, S. U. Emerson, and R. H. Purcell. 2000. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J. Virol. 74:5548-5555.
26. Schofield, D. J., R. H. Purcell, H. T. Nguyen, and S. U. Emerson. 2003.Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine. Vaccine 22:257-267.
27. Tsarev, S. A., T. S. Tsareva, S. U. Emerson, S. Govindarajan, M. Shapiro, J. L. Gerin, and R. H. Purcell. 1997. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 15:1834-1838.
28. Worm, H. C., and G. Wirnsberger. 2004. Hepatitis E vaccines: progress and prospects. Drugs 64:1517-1531.
29. Xiao, C., and M. G. Rossmann. 2007. Interpretation of electron density with stereographic roadmap projections. J. Struct. Biol. 158:181-186.
30. Xing, L., K. Kato, T. Li, N. Takeda, T. Miyamura, L. Hammar, and R. H.Cheng. 1999. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T=1 particle presenting native virus epitopes. Virology 265:35-45.
31. Xing, L., T. C. Li, N. Miyazaki, M. N. Simon, J. S. Wall, M. Moore, C. Y. Wang, N. Takeda, T. Wakita, T. Miyamura, and R. H. Cheng. 2010. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J. Biol. Chem. 285:33175-33183.
32. Yamashita, T., Y. Mori, N. Miyazaki, H. Cheng, M. Yoshimura, H. Unno, R. Shima, K. Moriishi, T. Tsukihara, T. C. Li, N. Takeda, T. Miyamura, and Y. Matsuura. 2009. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. U. S. A. 106:12986-12991.
33. Zhou, Y. H., R. Purcell, and S. Emerson. 2005. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to nonvaccine sequences following challenge of vaccinated and nonvaccinated macaques with hepatitis E virus. Vaccine 23:3157-3165.